{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "17768133", "DateCompleted": {"Year": "2008", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1592-8721", "JournalIssue": {"Volume": "92", "Issue": "9", "PubDate": {"Year": "2007", "Month": "Sep"}}, "Title": "Haematologica", "ISOAbbreviation": "Haematologica"}, "ArticleTitle": "Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients.", "Pagination": {"StartPage": "1289", "EndPage": "1290", "MedlinePgn": "1289-90"}, "Abstract": {"AbstractText": ["Current treatments for bisphosphonate-associated osteonecrosis of the jaw (ONJ) in multiple myeloma patients have limited efficacy. The biological effects of ozone indicate it may be therapeutic for ONJ. We, here, report the efficacy of a 15-day course of antibiotics, surgery and ozone therapy in 12 MM patients with ONJ."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Petrucci", "ForeName": "Maria Teresa", "Initials": "MT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gallucci", "ForeName": "Cristiano", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Agrillo", "ForeName": "Alessandro", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mustazza", "ForeName": "Maria Cristina", "Initials": "MC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fo\u00e0", "ForeName": "Robin", "Initials": "R"}], "PublicationTypeList": ["Letter"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Haematologica", "NlmUniqueID": "0417435", "ISSNLinking": "0390-6078"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Diphosphonates"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Diphosphonates"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced", "therapy"], "DescriptorName": "Jaw Diseases"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["complications", "drug therapy"], "DescriptorName": "Multiple Myeloma"}, {"QualifierName": ["chemically induced", "therapy"], "DescriptorName": "Osteonecrosis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "9", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "2", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "9", "Day": "5", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17768133", "10.3324/haematol.11096"]}}], "PubmedBookArticle": []}